Candriam S.C.A. Xencor Inc Transaction History

Candriam S.C.A.

$17.1 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	SELL	$18.21 - $24.5 $6.22 Million - $8.36 Million	-341,298 Reduced 52.4%	310,019 $5.87 Million
Q1 2024 May 03, 2024	SELL	$18.65 - $26.52 $1.06 Million - $1.5 Million	-56,667 Reduced 8.0%	651,317 $14.4 Million
Q4 2023 Feb 14, 2024	BUY	$16.53 - $21.42 $909,150 - $1.18 Million	55,000 Added 8.42%	707,984 $15 Million
Q2 2023 Aug 08, 2023	SELL	$24.77 - $29.9 $1.13 Million - $1.36 Million	-45,435 Reduced 6.51%	652,984 $16.3 Million
Q1 2023 May 12, 2023	SELL	$25.95 - $36.95 $232,226 - $330,665	-8,949 Reduced 1.27%	698,419 $19.5 Million
Q4 2022 Feb 13, 2023	SELL	$24.79 - $30.86 $697,912 - $868,801	-28,153 Reduced 3.83%	707,368 $18.4 Million
Q3 2022 Nov 10, 2022	SELL	$24.62 - $32.44 $4.29 Million - $5.65 Million	-174,178 Reduced 19.15%	735,521 $19.1 Million
Q2 2022 Aug 03, 2022	BUY	$19.74 - $29.01 $645,853 - $949,149	32,718 Added 3.73%	909,699 $24.9 Million
Q1 2022 May 13, 2022	BUY	$26.68 - $41.63 $1.22 Million - $1.9 Million	45,642 Added 5.49%	876,981 $23.4 Million
Q4 2021 Feb 10, 2022	BUY	$33.67 - $43.44 $6.52 Million - $8.41 Million	193,539 Added 30.34%	831,339 $33.4 Million
Q3 2021 Nov 09, 2021	BUY	$30.65 - $35.68 $4.08 Million - $4.75 Million	133,256 Added 26.41%	637,800 $20.8 Million
Q2 2021 Jul 20, 2021	SELL	$34.33 - $44.68 $373,098 - $485,582	-10,868 Reduced 2.11%	504,544 $17.4 Million
Q1 2021 Apr 29, 2021	SELL	$40.81 - $53.88 $81 - $107	-2 Reduced -0.0%	515,412 $21.6 Million
Q4 2020 Jan 22, 2021	SELL	$36.63 - $47.63 $7.92 Million - $10.3 Million	-216,273 Reduced 29.56%	515,414 $22.5 Million
Q3 2020 Oct 19, 2020	BUY	$30.09 - $43.02 $8.08 Million - $11.6 Million	268,595 Added 58.0%	731,687 $28.4 Million
Q2 2020 Jul 23, 2020	BUY	$27.76 - $33.42 $7.8 Million - $9.39 Million	280,916 Added 154.2%	463,092 $15 Million
Q1 2020 May 26, 2020	BUY	$20.69 - $37.79 $496 - $906	24 Added 0.01%	182,176 $6.13 Million
Q4 2019 Jan 21, 2020	BUY	$32.75 - $41.43 $5.97 Million - $7.55 Million	182,152 New	182,152 $6,000

Others Institutions Holding XNCR

# of Institutions

215

Shares Held

71.8M

Call Options Held

2.5K

Put Options Held

7.9K

Black Rock Inc. New York, NY

11.1M
Shares

$256 Million
0.0% of portfolio
Primecap Management CO Pasadena, CA

9.14M
Shares

$211 Million
0.14% of portfolio
Vanguard Group Inc Valley Forge, PA

7.6M
Shares

$175 Million
0.0% of portfolio
Eco R1 Capital, LLC San Francisco, CA

5.33M
Shares

$123 Million
4.65% of portfolio
Price T Rowe Associates Inc Baltimore, MD

3.93M
Shares

$90.6 Million
0.01% of portfolio

View Full List

About Xencor Inc

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.38B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

More about XNCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.

Account